Tag: risk

Guangzhou, China, June 23, 2025 (GLOBE NEWSWIRE) -- The "2025 International Supply Chain Conference of Chinese Cuisine," hosted by Wuhan Liangzhilong Food Inc., officially opened at Zone D of the Canton Fair Complex in Guangzhou. The event brought together representatives from 17 industry associations, over 100 supply chain platforms, and leading chain restaurant enterprises to explore how businesses can leverage localization, standardization, and digitalization strategies to break into international markets during what is being hailed as the inaugural year of Chinese cuisine’s global supply chain expansion. The focus is shifting from simply "selling flavors" to "selling the entire supply chain."

Industry analysis confirms that Jackbit’s no-KYC policy and expansive library of over 7,000 casino games continue to drive strong player demand—reinforced by its growing popularity among members of the Reddit gambling community.

ARLINGTON, TX, June 23, 2025 (GLOBE NEWSWIRE) -- Greenway Technologies, Inc. (OTCQB: GWTI) (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announced today that it has successfully uplisted its common stock from the OTC^® Pink Market to the OTCQB^® Venture Market (“OTCQB”). The uplisting was processed and approved by OTC Markets Group Inc., and Greenway’s common stock commenced trading on the OTCQB on June 20, 2025. Greenway will continue to trade under the ticker symbol “GWTI.” To be eligible for the OTCQB, companies must be current in their reporting and must undergo an annual verification and management certification process.

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression

Board of Directors Announces Restructuring Plan

En attendant la décision finale de la Commission européenne, le régime offre une nouvelle norme de soins pour les patients éligibles atteints d’LMC^1,2